3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant Meeting Abstract


Authors: Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; O'Dwyer, K. M.; Baer, M. R.; Schiller, G. J.; Abedi, M.; Minnema, M. C.; Stiff, P.; Zhou, L.; Hadjivassileva, T.; Khalid, R. Damico; Ghobadi, A. Armin
Abstract Title: 3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant
Meeting Title: 17th International Conference on Malignant Lymphoma (ICML)
Journal Title: Hematological Oncology
Volume: 41
Issue: Suppl. 2
Meeting Dates: 2023 Jun 13-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2023-06-01
Start Page: 520
End Page: 521
Language: English
DOI: 10.1002/hon.3164_385
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 385 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jae Hong Park
    356 Park